tiprankstipranks
DNAPrint Genomics Inc (DNAG)
OTHER OTC:DNAG
US Market

DNAPrint Genomics (DNAG) Stock Price & Analysis

10 Followers

DNAG Stock Chart & Stats

Currently, no data available
Please return soon. This page is being updated.

Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

0.00%0.00%0.18%99.82%
0.00%
Insiders
0.00%
Mutual Funds
0.18% Other Institutional Investors
99.82% Public Companies and
Individual Investors

DNAG FAQ

What was DNAPrint Genomics Inc’s price range in the past 12 months?
Currently, no data Available
What is DNAPrint Genomics Inc’s market cap?
Currently, no data Available
When is DNAPrint Genomics Inc’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were DNAPrint Genomics Inc’s earnings last quarter?
Currently, no data Available
Is DNAPrint Genomics Inc overvalued?
According to Wall Street analysts DNAPrint Genomics Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
    Does DNAPrint Genomics Inc pay dividends?
    DNAPrint Genomics Inc does not currently pay dividends.
    What is DNAPrint Genomics Inc’s EPS estimate?
    DNAPrint Genomics Inc’s EPS estimate for its next earnings report is not yet available.
    How many shares outstanding does DNAPrint Genomics Inc have?
    DNAPrint Genomics Inc has 644,610,000 shares outstanding.
      What happened to DNAPrint Genomics Inc’s price movement after its last earnings report?
      Currently, no data Available
      Which hedge fund is a major shareholder of DNAPrint Genomics Inc?
      Currently, no hedge funds are holding shares in DNAG
      ---

      DNAPrint Genomics Stock Smart Score

      N/A
      Not Ranked
      1
      2
      3
      4
      5
      6
      7
      8
      9
      10

      Company Description

      DNAPrint Genomics Inc

      DNAPrint Genomics, Inc. engages in the research and development of genomics-based products and services for biomedical and forensics. The company was founded by Tony N. Frudakis on January 3, 1983 and is headquartered in Sarasota, FL.
      ---
      Similar Stocks
      Company
      Price & Change
      Follow
      Intellia Therapeutics
      Crispr Therapeutics AG
      Editas Medicine
      Sangamo Biosciences
      Popular Stocks
      ---
      What's Included in PREMIUM?
      Make informed decisions based on Top Analysts' activity
      Know what industry insiders are buying
      Get actionable alerts from top Wall Street Analysts
      Find out before anyone else which stock is going to shoot up
      Get powerful stock screeners & detailed portfolio analysis